The global Drug Testing market size is expected to be worth around US$ 21.7 billion by 2030, according to a new report by Vision Research Reports.
The global Drug Testing market size was valued at US$ 10.1 billion in 2020 and is anticipated to grow at a CAGR of 8.9% during forecast period 2021 to 2030.
Growth Factors
The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.
Report Highlights
The consumables segment dominated the market in 2020 with a revenue share of 38.3%. The increasing launch of advanced consumables that provide improved solutions to make testing easy, accurate, and fast have accelerated the market growth.
The urine samples segment dominated the market and accounted for the largest revenue share of 44.8% in 2020. The segment is projected to grow at the fastest rate during the forecast period. This high growth can be attributed to the fact that urine samples are the most commonly used sample type to detect the presence of illicit substances. However, adulteration is becoming highly common in urine samples to produce a false-negative test result, which can adversely impact market growth.
On the other hand, the oral fluid sample segment accounted for the significant market share as it is a quicker and less invasive sample to collect at the roadside. According to NCBI 2020 study, a survey conducted among staff as well as patients concluded that oral fluid samples are preferred over urine samples as they help save time and maintain dignity, regardless of the extra costs.
The cannabis/marijuana segment dominated the drug testing market and accounted for the largest revenue share of 30.9% in 2020. This can be attributed to the fact that marijuana or cannabis is the most commonly used illicit substance in key markets, thus creating a high demand for its testing kits and instruments. According to the Substance Abuse and Mental Health Services Administration, in 2018, the most commonly used illicit drug in the U.S. was marijuana, which was used by about 43.5 million people.
The Opioids segment held the second-largest revenue share in 2020. This high share can be attributed to increased opioid crises in key markets including North America and the introduction of innovative opioid testing solutions. In July 2017, Alere Inc., a subsidiary of Abbott Laboratories, launched Alere iCup Rx Drug Screen. This rapid point-of-care urine test developed for the detection of the most commonly abused prescription medications such as buprenorphine, benzodiazepines, opiates, methadone, and oxycodone.
Drug testing laboratories dominated the market and held the largest revenue share of 40.0% in 2020. This high share can be attributed to their wide acceptance due to their accurate results. Drug testing laboratories can test for the presence of any illicit substance, which is not possible with rapid tests. Additional advantages of drug testing laboratories include the availability of sophisticated equipment, such as HPLC and spectroscopy, and trained personnel for conducting tests for effective results. Therefore, laboratories provide testing results with more sensitivity and specificity as compared to rapid tests.
Workplaces are projected to be the fastest-growing segment over the forecast period owing to the rising use of substance abuse screening in pre-employment as well as random drug tests to ensure drug-free premises. Moreover, in case of workplace accidents, drug tests can be used to check if the accident happened under influence of drugs, thus removing the responsibility of the employer for damages. Companies spend over USD 3,750 million on drug testing.
North America dominated the market and held the largest revenue share of 40.1% in 2020 and is projected to maintain the lead throughout the forecast period. The presence of prominent players implementing extensive expansion strategies and rigid regulations for workplace testing are some of the major factors contributing to the region’s leading share. Also, favorable reimbursement scenarios and the high adoption of technologically advanced solutions in the region have further supported the market growth.
In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse screening from emerging economies, such as China and India. The rising prevalence of substance abuse disorders, drug-related crimes, and fatal road accidents has boosted the demand for drug testing in these countries. However, the lack of clear regulations related to workplace drug testing is anticipated to be a major factor hampering the market growth.
Report Coverage | Details |
Market Size | US$ 21.7 billion by 2030 |
Growth Rate |
CAGR of 8.9% From 2021 to 2030 |
Base Year | 2020 |
Forecast Year | 2021 to 2030 |
Segments Covered | Product Type, Sample Type, Drug Type, End-use, Region |
Companies Mentioned | Quest Diagnostics Incorporated; Abbott Laboratories; Quidel Corporation; F. Hoffmann-La Roche; Thermo Fisher Scientific, Inc.; Siemens Healthineers; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; LabCorp; Drägerwerk AG & CO. KGaA; Clinical Reference Laboratory (CRL), Inc.; Cordant Health Solutions; Legacy Medical Services, LLC; Omega laboratories, Inc. |
Key Players
Quest Diagnostics Incorporated
Abbott Laboratories
Quidel Corporation
F. Hoffmann-La Roche
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
LabCorp
Drägerwerk AG & CO. KGaA
Clinical Reference Laboratory (CRL), Inc.
Cordant Health Solutions
Legacy Medical Services, LLC
Omega Laboratories, Inc.
Market Segmentation
Product Type Outlook
Consumables
Instruments
Rapid Testing Devices
Services
Sample Type Outlook
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
Drug Type Outlook
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
End-use Outlook
Drug Testing Laboratories
Workplaces
Hospitals
Others
Regional Outlook
North America
U.S.
Canada
Europe
Germany
U.K.
Spain
France
Italy
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Chile
MEA
South Africa
Saudi Arabia
UAE
The Drug Testing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Drug Testing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Drug Testing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Testing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Drug Testing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Drug Testing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Drug Testing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Drug Testing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Drug Testing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Drug Testing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Drug Testing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Drug Testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Drug Testing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Drug Testing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Drug Testing market. These factors have benefited the growth of the global market for Drug Testing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Drug Testing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Drug Testing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Drug Testing Market, By Product Type
7.1. Drug Testing Market, by Product Type, 2020-2030
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Rapid Testing Devices
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Services
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Drug Testing Market, By Sample Type
8.1. Drug Testing Market, by Sample Type, 2020-2030
8.1.1. Urine Samples
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Oral Fluid Samples
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Hair Samples
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Other Samples
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Drug Testing Market, By Drug Type
9.1. Drug Testing Market, by Drug Type, 2020-2030
9.1.1. Alcohol
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Cannabis/Marijuana
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Cocaine
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Opioids
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Amphetamine & Methamphetamine
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. LSD
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Drug Testing Market, By End-use
10.1. Drug Testing Market, by End-use, 2020-2030
10.1.1. Drug Testing Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Workplaces
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Hospitals
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Drug Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.1.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.1.4. Market Revenue and Forecast, by End-use (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, by End-use (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.2.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.2.4. Market Revenue and Forecast, by End-use (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, by End-use (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, by End-use (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, by End-use (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.3.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.3.4. Market Revenue and Forecast, by End-use (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, by End-use (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, by End-use (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, by End-use (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.4.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.4.4. Market Revenue and Forecast, by End-use (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, by End-use (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, by End-use (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, by End-use (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, by End-use (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Sample Type (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Drug Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 12. Company Profiles
12.1. Quest Diagnostics Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Quidel Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F. Hoffmann-La Roche
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Thermo Fisher Scientific, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Siemens Healthineers
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. LabCorp
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Drägerwerk AG & CO. KGaA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Clinical Reference Laboratory (CRL), Inc.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Cordant Health Solutions
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Legacy Medical Services, LLC
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Omega Laboratories, Inc.
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms